Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumours
Lars Custers, Eleonora Khabirova, Tim H. H. Coorens, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Cancers make their own luck: theories of cancer origins
Amir Jassim, Eric P. Rahrmann, Benjamin D. Simons, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 10, pp. 710-724
Open Access | Times Cited: 118
Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy
Yaniv Kazansky, Daniel Cameron, Helen S. Mueller, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 965-981
Open Access | Times Cited: 18
SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities
Garrett W. Cooper, Andrew L. Hong
Cancers (2022) Vol. 14, Iss. 15, pp. 3645-3645
Open Access | Times Cited: 43
Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemia
Nathaniel D. Anderson, Jack Birch, Théo Accogli, et al.
Nature Medicine (2023) Vol. 29, Iss. 7, pp. 1700-1709
Open Access | Times Cited: 41
Cancer Evolution: A Multifaceted Affair
Giovanni Ciriello, Luca Magnani, Sarah J. Aitken, et al.
Cancer Discovery (2023) Vol. 14, Iss. 1, pp. 36-48
Open Access | Times Cited: 27
Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma
Jeff DeMartino, Michael T. Meister, Lindy L. Visser, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers
Daniela Perotti, Maureen J. O’Sullivan, Amy L. Walz, et al.
Nature Reviews Urology (2025)
Closed Access | Times Cited: 1
Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer
Seok-Young Kim, Tamar A. E. de Weert, Marijn A. Vermeulen, et al.
Science Advances (2025) Vol. 11, Iss. 9
Closed Access | Times Cited: 1
Compromised epigenetic robustness in cancer: fueling evolution, exposing weakness
Thomas Stuart Wilson, Paola Scaffidi
Trends in cancer (2025)
Open Access | Times Cited: 1
Human embryo polarization requires PLC signaling to mediate trophectoderm specification
Meng Zhu, Marta N. Shahbazi, Ángel Martín, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 45
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes
Michael T. Meister, Marian J.A. Groot Koerkamp, Terezinha de Souza, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 10
Open Access | Times Cited: 37
Somatic variation in normal tissues: friend or foe of cancer early detection?
Amelia Acha‐Sagredo, Piyali Ganguli, Francesca D. Ciccarelli
Annals of Oncology (2022) Vol. 33, Iss. 12, pp. 1239-1249
Open Access | Times Cited: 29
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor
Elizabeth Alva, Jeffrey Rubens, Susan Chi, et al.
Neoplasia (2023) Vol. 37, pp. 100880-100880
Open Access | Times Cited: 19
SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance
Bujamin Vokshi, Guillaume Davidson, Nassim Tawanaie Pour Sedehi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Toward reproducible tumor organoid culture: focusing on primary liver cancer
Lianming Guo, Chao Li, Weiqiang Gong
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
SMARCA4 and SMARCA2 co-deficiency: An uncommon molecular signature defining a subset of rare, aggressive and undifferentiated malignancies associated with defective chromatin remodeling.
Natisha Field, Kristie-Ann Dickson, Najah T. Nassif, et al.
Cancer Letters (2024), pp. 217282-217282
Open Access | Times Cited: 7
Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors
Camilla Calandrini, Sander R. van Hooff, Irene Paassen, et al.
Cell Reports (2021) Vol. 36, Iss. 8, pp. 109568-109568
Open Access | Times Cited: 40
Single cell derived mRNA signals across human kidney tumors
Matthew D. Young, Thomas J. Mitchell, Lars Custers, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 39
Induction of senescence-associated secretory phenotype underlies the therapeutic efficacy of PRC2 inhibition in cancer
Liping Chu, Yu-Xiu Qu, Yang An, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 28
Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch
Annelisa M. Cornel, Ester Dünnebach, Damon A. Hofman, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e005002-e005002
Open Access | Times Cited: 26
Current and Emerging Therapeutic Approaches for Extracranial Malignant Rhabdoid Tumors
Karolina Nemes, Pascal D. Johann, Stefanie Tüchert, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 479-498
Open Access | Times Cited: 24
Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors
Cinzia Lanzi, Noemi Arrighetti, Sandro Pasquali, et al.
Biochemical Pharmacology (2023) Vol. 215, pp. 115727-115727
Closed Access | Times Cited: 13
Knocking Out CD70 Rescues CD70-Specific NanoCAR T Cells from Antigen-Induced Exhaustion
Stijn De Munter, Juliane L. Buhl, Laurenz De Cock, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 9, pp. 1236-1251
Open Access | Times Cited: 5
Characteristics and outcome of children with renal tumors in the Netherlands: The first five-year’s experience of national centralization
Prakriti Roy, Sophie E. van Peer, Martin M. de Witte, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0261729-e0261729
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top